Come the weekend, we will have passed the 9 month mark between the completion of the ARS dosing study and the silence that has followed since.
As a time frame for reference, it took 7 months between completion of mouse trial to the announcement they will be conducting dosing trial.
This delay is agonizing to say the least. Spidey had mentioned the possibility of ethics or trying to get the design perfect. Not too sure I'm agreeing with that explanation. Like I said before, an announcement that they will be proceeding does not need either of these. Really the only thing we ever hear are terms like discussing, advancing, and progressing when it comes to this trial. The DOD was encouraging, but since zip.
This dosing trial and the results we have seen, were pretty much a non event when it comes to investor interest and of course, price. I was truly surprised of the lack of this. We closed 1 penny higher than the previous day, with volume of 1.3 million. Not exactly stellar. What was it that big investors, analysts, people with vast more resources than most, see in this that trial that basically just made this a non event. I think it surprised the company also, as a week or two later Zami did a video that seemed like they were just trying to put something out there because of this lack of interest. Kind of like, did you not see this great release we just had.
We can try to assess the merits of the results we have. Obviously the street wasn't impressed in the least. Spidey has been great in helping to explain the results. I'm sure many biotech stock experts have seen the results as well, along with other things this company has on the go. Big question is why are they not impressed? What do they see that we don't? And now, why this continued delay with nothing being said except a blurb in presentations.
If it's the funding of this that's the holdup, just do it for free like you have the others. Supply what, 300 to 500 doses that cost you what? Even at $7 grand a dose which was a number I seem to recall, you're looking at $3.5 million. I really can't see it being anywhere close to that as I would think one run in a bioreactor would make enough. But even if it was, getting this show on the road seems imperative imo.
Again, like always, I just wish the company would talk to us in a way other than presentations. Even give a scripted interview like you have in the past. The thing too with CC's that is beneficial, is it puts it on record what they say. Makes them have to be accountable for what they say. Maybe that's the reason they fear them so much.
Just give us something really. I can now say...
We'll get em next month.
AI
